Cargando…

A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor Survival

BACKGROUND: CD39 is one of the functional surface markers for T regulatory cells, the prognostic role and immune-related effects of CD39 in luminal breast cancer (BC) patients has not been evaluated yet. The aim of the current study was to explore the association between CD39 expression and clinic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Xiaojian, Wan, Wenze, Ma, Jingjing, Liu, Xinyou, Zheng, Bohao, He, Zhixian, Yang, Weige, Huang, Lihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250154/ https://www.ncbi.nlm.nih.gov/pubmed/34220957 http://dx.doi.org/10.3389/fgene.2021.682503

Ejemplares similares

Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
por: Amorim, Maria, et al.
Publicado: (2019)

LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer
por: Fonseca-Montaño, Marco Antonio, et al.
Publicado: (2023)

CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease
por: Kudryavtsev, Igor, et al.
Publicado: (2019)

CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma
por: Li, Xinwei, et al.
Publicado: (2022)

CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer
por: Wang, Jianxin, et al.
Publicado: (2020)

Single-cell profiling defines the prognostic benefit of CD39(high) tissue resident memory CD8+ T cells in luminal-like breast cancer
por: Losurdo, Agnese, et al.
Publicado: (2021)

SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients
por: Liu, Fangshu, et al.
Publicado: (2023)

High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker
por: Dong, Xingxing, et al.
Publicado: (2021)

Integrative Transcriptomic, Lipidomic, and Metabolomic Analysis Reveals Potential Biomarkers of Basal and Luminal Muscle Invasive Bladder Cancer Subtypes
por: Feng, Chao, et al.
Publicado: (2021)

Integrative Bioinformatics Analysis Reveals CHEK1 and UBE2C as Luminal A Breast Cancer Subtype Biomarkers
por: Yu, Daowu, et al.
Publicado: (2022)

Identification of Potential Prognostic Biomarker for Predicting Survival in Multiple Myeloma Using Bioinformatics Analysis and Experiments
por: Zhou, Jian, et al.
Publicado: (2021)

Author Correction: Single-cell profiling defines the prognostic benefit of CD39(high) tissue resident memory CD8+ T cells in luminal-like breast cancer
por: Losurdo, Agnese, et al.
Publicado: (2021)

Identification of CD161 expression as a novel prognostic biomarker in breast cancer correlated with immune infiltration
por: Weng, Miaomiao, et al.
Publicado: (2022)

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Pan-cancer analysis of the prognostic and immunological role of Fanconi anemia complementation group E
por: Zhou, Zhixian, et al.
Publicado: (2023)

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
por: Althobiti, Maryam, et al.
Publicado: (2021)

Luminal A Breast Cancer Co-expression Network: Structural and Functional Alterations
por: García-Cortés, Diana, et al.
Publicado: (2021)

DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC
por: Sun, Yang, et al.
Publicado: (2022)

SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer
por: Huo, Qin, et al.
Publicado: (2020)

Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
por: Zhang, Peng, et al.
Publicado: (2019)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

OSluca: An Interactive Web Server to Evaluate Prognostic Biomarkers for Lung Cancer
por: Yan, Zhongyi, et al.
Publicado: (2020)

Apolipoprotein E Overexpression Is Associated With Tumor Progression and Poor Survival in Colorectal Cancer
por: Zhao, Zhixun, et al.
Publicado: (2018)

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
por: Baccelli, Irène, et al.
Publicado: (2014)

Biliverdin reductase B impairs cholangiocarcinoma cell motility by inhibiting the Notch/Snail signaling pathway
por: Gao, Zhihui, et al.
Publicado: (2022)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

The Role of Copy Number Variants in Gene Co-Expression Patterns for Luminal B Breast Tumors
por: Hernández-Gómez, Candelario, et al.
Publicado: (2022)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

Investigating CENPW as a Novel Biomarker Correlated With the Development and Poor Prognosis of Breast Carcinoma
por: Wang, Luyang, et al.
Publicado: (2022)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
por: Gardani, Carla Fernanda Furtado, et al.
Publicado: (2023)

Limitations of Explainability for Established Prognostic Biomarkers of Prostate Cancer
por: Manjang, Kalifa, et al.
Publicado: (2021)

Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer
por: Einama, T, et al.
Publicado: (2012)

Identification of CD8(+) T Cell Related Biomarkers in Ovarian Cancer
por: Li, Ling, et al.
Publicado: (2022)

Hypoxia-Induced miR-148a Downregulation Contributes to Poor Survival in Colorectal Cancer
por: Nersisyan, Stepan, et al.
Publicado: (2021)

FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer
por: Tong, Fei, et al.
Publicado: (2023)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”
por: Höller, Anna, et al.
Publicado: (2023)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_49bt0op4h0vu3b9ekumqop84bl